Foresight invests £3.0 million into MyWay Digital Health

• MyWay Digital Health delivers data-driven technology to support the management of long-term health conditions, with a particular focus on diabetes
• Foresight’s investment will accelerate product development and enhance global commercial expansion

Edinburgh, 1 September, 2025: Foresight Group (“Foresight”) a leading regional private equity and infrastructure investment manager, has announced a £3.0 million investment into MyWay Digital Health Ltd (“MWDH” or the “Company”), a digital healthcare solutions provider dedicated to reducing the burden of chronic disease, with a particular emphasis on diabetes.

Spun out of the University of Dundee in 2017, MWDH employs 30 staff across Dundee, Edinburgh, and London. The Company’s mission is to improve the lives of individuals living with long-term conditions through cost-effective, data-driven, personalised health technology. Its suite of products spans diabetes prevention, cardiovascular health, hypertension, and weight management.

MWDH’s flagship platform, MyWay Diabetes, is a clinically validated digital self-management tool that integrates with NHS systems to provide personalised education, data visualisation, and actionable insights for patients and clinicians. The platform has been adopted across multiple NHS regions and internationally, demonstrating measurable improvements in patient engagement and health outcomes.

Foresight’s investment will enable MWDH to accelerate the development of new AI-enabled products, including predictive analytics and personalised care pathways, while expanding its commercial footprint to meet growing global demand for scalable digital health solutions.

To support the Company’s growth strategy, Dr Umang Patel will join as Non-Executive Chair. Dr Patel brings extensive experience from the technology and healthcare sectors and currently serves as Chief Clinical Information Officer for Microsoft in the EMEA region. He will work closely with the management team to drive both domestic and international expansion.

Debbie Wake, CEO and Co-Founder, of MWDH, said: “We are delighted to have secured investment from Foresight, marking a significant milestone in MWDH’s journey. Their support will enable us to accelerate our growth strategy, broaden our product offering, and further expand our global footprint.”

Daniel Halliday, Managing Director at Foresight Group, commented: “The adoption of digital tools and AI to reduce the burden on frontline care is critical. MWDH is at the forefront of this and its best in class technology is proven to deliver better health outcomes and cost savings for its customers. Foresight is excited to support the team on their next phase of growth.”

Foresight invests in promising growing companies, providing equity or debt to meet the needs of founders and management teams. We also offer tailored and flexible debt financing facilities to specialist, non-bank lenders. Foresight works with the growing companies it supports to enable founders and management teams to build resilient and prosperous companies to deliver strong economic returns and to have a positive impact on the societies in which they operate.